These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 36433737)

  • 21. Developability Assessment of Engineered Monoclonal Antibody Variants with a Complex Self-Association Behavior Using Complementary Analytical and in Silico Tools.
    Shan L; Mody N; Sormani P; Rosenthal KL; Damschroder MM; Esfandiary R
    Mol Pharm; 2018 Dec; 15(12):5697-5710. PubMed ID: 30395473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid Affinity Maturation of Novel Anti-PD-L1 Antibodies by a Fast Drop of the Antigen Concentration and FACS Selection of Yeast Libraries.
    Cembrola B; Ruzza V; Troise F; Esposito ML; Sasso E; Cafaro V; Passariello M; Visconte F; Raia M; Del Vecchio L; D'Alise AM; Cortese R; Scarselli E; Zambrano N; De Lorenzo C; Nicosia A
    Biomed Res Int; 2019; 2019():6051870. PubMed ID: 31976323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Highly sensitive detection of antibody nonspecific interactions using flow cytometry.
    Makowski EK; Wu L; Desai AA; Tessier PM
    MAbs; 2021; 13(1):1951426. PubMed ID: 34313552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ultradilute Measurements of Self-Association for the Identification of Antibodies with Favorable High-Concentration Solution Properties.
    Starr CG; Makowski EK; Wu L; Berg B; Kingsbury JS; Gokarn YR; Tessier PM
    Mol Pharm; 2021 Jul; 18(7):2744-2753. PubMed ID: 34105965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimal charged mutations in the complementarity-determining regions that prevent domain antibody aggregation are dependent on the antibody scaffold.
    Perchiacca JM; Lee CC; Tessier PM
    Protein Eng Des Sel; 2014 Feb; 27(2):29-39. PubMed ID: 24398633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid analysis of antibody self-association in complex mixtures using immunogold conjugates.
    Sule SV; Dickinson CD; Lu J; Chow CK; Tessier PM
    Mol Pharm; 2013 Apr; 10(4):1322-31. PubMed ID: 23383873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A fully synthetic human Fab antibody library based on fixed VH/VL framework pairings with favorable biophysical properties.
    Tiller T; Schuster I; Deppe D; Siegers K; Strohner R; Herrmann T; Berenguer M; Poujol D; Stehle J; Stark Y; Heßling M; Daubert D; Felderer K; Kaden S; Kölln J; Enzelberger M; Urlinger S
    MAbs; 2013; 5(3):445-70. PubMed ID: 23571156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of highly soluble antibodies prior to purification using affinity-capture self-interaction nanoparticle spectroscopy.
    Wu J; Schultz JS; Weldon CL; Sule SV; Chai Q; Geng SB; Dickinson CD; Tessier PM
    Protein Eng Des Sel; 2015 Oct; 28(10):403-14. PubMed ID: 26363633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Affinity maturation of Fab antibody fragments by fluorescent-activated cell sorting of yeast-displayed libraries.
    van den Beucken T; Pieters H; Steukers M; van der Vaart M; Ladner RC; Hoogenboom HR; Hufton SE
    FEBS Lett; 2003 Jul; 546(2-3):288-94. PubMed ID: 12832056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvement in affinity and thermostability of a fully human antibody against interleukin-17A by yeast-display technology and CDR grafting.
    Sun W; Yang Z; Lin H; Liu M; Zhao C; Hou X; Hu Z; Cui B
    Acta Pharm Sin B; 2019 Sep; 9(5):960-972. PubMed ID: 31649846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systematic Engineering of Optimized Autonomous Heavy-Chain Variable Domains.
    Nilvebrant J; Ereño-Orbea J; Gorelik M; Julian MC; Tessier PM; Julien JP; Sidhu SS
    J Mol Biol; 2021 Oct; 433(21):167241. PubMed ID: 34508727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A tetravalent bispecific TandAb (CD19/CD3), AFM11, efficiently recruits T cells for the potent lysis of CD19(+) tumor cells.
    Reusch U; Duell J; Ellwanger K; Herbrecht C; Knackmuss SH; Fucek I; Eser M; McAleese F; Molkenthin V; Gall FL; Topp M; Little M; Zhukovsky EA
    MAbs; 2015; 7(3):584-604. PubMed ID: 25875246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simplifying complex antibody engineering using machine learning.
    Makowski EK; Chen HT; Tessier PM
    Cell Syst; 2023 Aug; 14(8):667-675. PubMed ID: 37591204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-PD1 'SHR-1210' aberrantly targets pro-angiogenic receptors and this polyspecificity can be ablated by paratope refinement.
    Finlay WJJ; Coleman JE; Edwards JS; Johnson KS
    MAbs; 2019 Jan; 11(1):26-44. PubMed ID: 30541416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Separating clinical antibodies from repertoire antibodies, a path to in silico developability assessment.
    Negron C; Fang J; McPherson MJ; Stine WB; McCluskey AJ
    MAbs; 2022; 14(1):2080628. PubMed ID: 35771588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Construction of a large synthetic human Fab antibody library on yeast cell surface by optimized yeast mating.
    Baek DS; Kim YS
    J Microbiol Biotechnol; 2014 Mar; 24(3):408-20. PubMed ID: 24394194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Affinity maturation of tacrolimus antibody for improved immunoassay performance.
    Siegel RW; Baugher W; Rahn T; Drengler S; Tyner J
    Clin Chem; 2008 Jun; 54(6):1008-17. PubMed ID: 18403566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization and Modeling of Reversible Antibody Self-Association Provide Insights into Behavior, Prediction, and Correction.
    Mieczkowski C; Cheng A; Fischmann T; Hsieh M; Baker J; Uchida M; Raghunathan G; Strickland C; Fayadat-Dilman L
    Antibodies (Basel); 2021 Feb; 10(1):. PubMed ID: 33671864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Affinity maturation of a novel antagonistic human monoclonal antibody with a long VH CDR3 targeting the Class A GPCR formyl-peptide receptor 1.
    Douthwaite JA; Sridharan S; Huntington C; Hammersley J; Marwood R; Hakulinen JK; Ek M; Sjögren T; Rider D; Privezentzev C; Seaman JC; Cariuk P; Knights V; Young J; Wilkinson T; Sleeman M; Finch DK; Lowe DC; Vaughan TJ
    MAbs; 2015; 7(1):152-66. PubMed ID: 25484051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combinatorial mutagenesis with alternative CDR-L1 and -H2 loop lengths contributes to affinity maturation of antibodies.
    Brockmann EC; Pyykkö M; Hannula H; Khan K; Lamminmäki U; Huovinen T
    N Biotechnol; 2021 Jan; 60():173-182. PubMed ID: 33039698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.